Latest / Bend News Today | 2 Min News | The Daily News Now!
Daraxonrasib Doubles Survival for Stage 4 Pancreatic Cancer | Bend News
A groundbreaking cancer drug called daraxonrasib is revolutionizing treatment for stage four metastatic pancreatic cancer, potentially doubling life expectancy from six to thirteen months. For patients like 78-year-old John Johnson, it’s a “new breath of life,” offering precious time with loved ones and renewed hope. Thanks to the St. Charles Cancer Institute’s swift action, patients received this life-extending therapy even before FDA approval—showcasing the power of medical innovation and compassion in action. Listen in comfort:Get a discount on a Soli Pillow…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.